Literature DB >> 1379986

Suppression of C3H/HeJ cell activation by lipopolysaccharide endotoxin.

B M Sultzer1, J R Bandekar, R Castagna, K Abu-Lawi, M Sadeghian, A J Norin.   

Abstract

Earlier studies in our laboratory showed that the lipopolysaccharide (LPS) of Salmonella typhi, which fails to activate B lymphocytes of C3H/HeJ mice, can suppress proliferation and polyclonal antibody synthesis by these cells when they are stimulated by polyclonal activators. In order to determine what stage of the cell cycle was blocked, resting B cells from C3H/HeJ spleens were activated by using different mitogens in the presence of inhibitory concentrations of LPS and analyzed by flow cytometry, using acridine orange to stain DNA and RNA. LPS was found to inhibit the progression of cells into the G1 stage of the cell cycle. Furthermore, [3H]uridine uptake studies showed that RNA synthesis is inhibited during the early phase of activation. These results indicate that inhibition by LPS of the signalling process occurs during a critical period of the cell cycle when the cells become susceptible to the inhibitory effects of LPS. To examine whether LPS acts only on B cells or whether it can suppress other immunocompetent cells from C3H/HeJ mice, studies were carried out on activated thymocytes and macrophages. LPS was found to inhibit thymocyte proliferation stimulated by concanavalin A or the combination of phorbol myristate acetate and ionomycin. Prostaglandin E2 synthesis by macrophages was also blocked by LPS. Thus, LPS is a potent inhibitor of the functioning of the major immunocompetent cells of C3H/HeJ mice.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379986      PMCID: PMC257357          DOI: 10.1128/iai.60.9.3533-3538.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Genetic analysis of lymphocyte activation by lipopolysaccharide Endotoxin.

Authors:  B M Sultzer
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

2.  Genetic control of responses to bacterial lipopolysaccharides in mice. II. A gene that influences a membrane component involved in the activation of bone marrow-derived lymphocytes by lipipolysaccharides.

Authors:  J Watson; R Riblet
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

3.  The activation of C3H/HeJ cells by certain types of lipopolysaccharides.

Authors:  B M Sultzer; R Castagna
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

4.  Characterization of the lipid A component of genuine smooth-form lipopolysaccharide.

Authors:  B H Jiao; M Freudenberg; C Galanos
Journal:  Eur J Biochem       Date:  1989-04-01

5.  A new method for the extraction of R lipopolysaccharides.

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1969-06

6.  Lymphocyte stimulation: a rapid multiparameter analysis.

Authors:  Z Darzynkiewicz; F Traganos; T Sharpless; M R Melamed
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

7.  Lipopolysaccharides inhibit lymphosarcoma cells of bone marrow orgin.

Authors:  P Ralph; I Nakoinz
Journal:  Nature       Date:  1974-05-03       Impact factor: 49.962

8.  Enzymatically deacylated Neisseria lipopolysaccharide (LPS) inhibits murine splenocyte mitogenesis induced by LPS.

Authors:  A L Erwin; R E Mandrell; R S Munford
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

9.  Activation and proliferation signals in mouse B cells. VIII. Induction of DNA synthesis in B cells by a combination of calcium ionophores and phorbol myristate acetate.

Authors:  G G Klaus; A O'Garra; M K Bijsterbosch; M Holman
Journal:  Eur J Immunol       Date:  1986-01       Impact factor: 5.532

10.  Endotoxin protein: a B-cell mitogen and polyclonal activator of C3H/HeJ lymphocytes.

Authors:  B M Sultzer; G W Goodman
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.